HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johan Garssen Selected Research

Lactoglobulins (beta-Lactoglobulin)

1/2022Inhibition of cow's milk allergy development in mice by oral delivery of β-lactoglobulin-derived peptides loaded PLGA nanoparticles is associated with systemic whey-specific immune silencing.
1/2018PLGA nanoparticles loaded with beta-lactoglobulin-derived peptides modulate mucosal immunity and may facilitate cow's milk allergy prevention.
1/2017Dietary Intervention with β-Lactoglobulin-Derived Peptides and a Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates the Prevention of Whey-Induced Allergy in Mice by Supporting a Tolerance-Prone Immune Environment.
1/2016A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides.
11/2013Oral treatment with β-lactoglobulin peptides prevents clinical symptoms in a mouse model for cow's milk allergy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johan Garssen Research Topics

Disease

53Hypersensitivity (Allergy)
02/2022 - 09/2002
42Inflammation (Inflammations)
03/2022 - 02/2006
27Food Hypersensitivity (Food Allergy)
07/2022 - 05/2004
24Milk Hypersensitivity (Milk Allergy)
01/2022 - 05/2004
23Infections
03/2022 - 08/2002
19Asthma (Bronchial Asthma)
06/2022 - 09/2011
17Neoplasms (Cancer)
03/2022 - 11/2011
12Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 10/2011
10Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020 - 05/2008
9Anaphylaxis (Anaphylactic Shock)
01/2022 - 08/2007
9Human Influenza (Influenza)
09/2021 - 08/2006
7Multiple Myeloma
05/2022 - 11/2011
7Diarrhea
03/2022 - 03/2011
7Arthritis (Polyarthritis)
01/2019 - 02/2006
7Colitis
01/2018 - 01/2013
6Tuberculosis (Tuberculoses)
01/2019 - 01/2017
5Peanut Hypersensitivity (Peanut Allergy)
04/2019 - 01/2017
5Sarcoidosis (Schaumann Disease)
01/2018 - 01/2015
5Porcine Reproductive and Respiratory Syndrome (PRRS)
12/2017 - 01/2013
5Hepatitis B
01/2004 - 05/2002
4Autism Spectrum Disorder
01/2021 - 01/2017
4Autoimmune Diseases (Autoimmune Disease)
01/2020 - 09/2002
4Parkinson Disease (Parkinson's Disease)
01/2019 - 12/2017
4Leukemia
10/2018 - 11/2008
4Lung Diseases (Lung Disease)
11/2016 - 10/2011
4Atopic Dermatitis (Atopic Eczema)
08/2013 - 06/2010
3Respiratory Hypersensitivity
01/2021 - 11/2016
3Chronic Disease (Chronic Diseases)
01/2021 - 01/2013
3Atherosclerosis
01/2018 - 07/2011
3Lung Neoplasms (Lung Cancer)
01/2018 - 05/2015
3Communicable Diseases (Infectious Diseases)
10/2016 - 09/2002
3Eosinophilia
04/2015 - 11/2012
3Contact Dermatitis (Eczema, Contact)
09/2004 - 10/2003
2Eczema
07/2022 - 01/2019
2Abdominal Pain (Pain, Abdominal)
06/2022 - 01/2022
2COVID-19
02/2022 - 01/2020
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022 - 01/2016
2Body Weight (Weight, Body)
01/2022 - 07/2015
2Weight Gain
06/2021 - 06/2015

Drug/Important Bio-Agent (IBA)

36OligosaccharidesIBA
03/2022 - 08/2006
29CytokinesIBA
02/2022 - 03/2003
23Immunoglobulin E (IgE)IBA
02/2022 - 07/2002
17AllergensIBA
07/2022 - 01/2008
16Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
15PrebioticsIBA
03/2022 - 10/2005
15Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2008
11AntigensIBA
01/2021 - 05/2004
11Toll-Like Receptors (Toll-Like Receptor)IBA
11/2019 - 05/2008
10Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2022 - 01/2012
10Immunoglobulins (Immunoglobulin)IBA
01/2022 - 07/2002
10VaccinesIBA
03/2021 - 08/2002
9SmokeIBA
01/2022 - 02/2011
9MicroRNAs (MicroRNA)IBA
07/2020 - 01/2016
9OvalbuminIBA
06/2020 - 10/2005
9Pattern Recognition ReceptorsIBA
01/2018 - 01/2013
7Amino AcidsFDA Link
01/2022 - 01/2018
7Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 09/2011
7LipopolysaccharidesIBA
01/2022 - 02/2006
7Pharmaceutical PreparationsIBA
01/2021 - 02/2006
7CollagenIBA
04/2014 - 02/2011
6Peptides (Polypeptides)IBA
01/2022 - 11/2013
6Whey ProteinsIBA
07/2021 - 01/2016
6AntibodiesIBA
01/2019 - 05/2002
6Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2018 - 12/2007
6Messenger RNA (mRNA)IBA
01/2018 - 01/2013
6ZymosanIBA
01/2018 - 02/2006
6Dextrans (Dextran)FDA Link
12/2017 - 01/2013
6Immunoglobulin G (IgG)IBA
10/2013 - 05/2002
5Lactoglobulins (beta-Lactoglobulin)FDA Link
01/2022 - 11/2013
5deoxynivalenolIBA
09/2021 - 06/2015
5PectinsIBA
01/2020 - 06/2007
5sodium sulfate (sodium bisulfate)FDA LinkGeneric
12/2017 - 01/2013
4Eicosapentaenoic AcidIBA
05/2022 - 02/2018
4Bortezomib (Velcade)FDA Link
05/2022 - 01/2014
4LigandsIBA
04/2019 - 01/2014
4Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2019 - 01/2017
4Budesonide (Pulmicort)FDA LinkGeneric
01/2018 - 04/2014
4ChemokinesIBA
01/2018 - 05/2008
4Interleukin-10 (Interleukin 10)IBA
01/2018 - 05/2004
4Proline (L-Proline)FDA Link
04/2014 - 10/2011
3Docosahexaenoic AcidsIBA
05/2022 - 02/2018
3Interleukin-13IBA
01/2022 - 11/2012
3Volatile Fatty AcidsIBA
11/2021 - 01/2017
3Fatty Acids (Saturated Fatty Acids)IBA
10/2021 - 04/2011
3Glutamic Acid (Glutamate)FDA Link
06/2021 - 04/2014
3Interleukin-6 (Interleukin 6)IBA
11/2019 - 11/2011
3Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2019 - 01/2017
32'-fucosyllactoseIBA
11/2019 - 01/2018
3RNA (Ribonucleic Acid)IBA
06/2018 - 12/2016
3Interleukin-17 (Interleukin 17)IBA
01/2017 - 12/2013
3Transcription Factors (Transcription Factor)IBA
04/2014 - 01/2013
3Caseins (Casein)FDA Link
03/2013 - 01/2008
2SeleniumIBA
02/2022 - 07/2021
2LeptinIBA
01/2022 - 10/2021
2Interleukin-4 (Interleukin 4)IBA
10/2021 - 11/2012
2VitaminsIBA
10/2021 - 01/2020

Therapy/Procedure

15Therapeutics
01/2022 - 05/2008
10Immunotherapy
01/2020 - 11/2013
6Drug Therapy (Chemotherapy)
03/2022 - 07/2011
3Immunomodulation
03/2021 - 09/2002